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Abstract 
 
The objective of this paper is to study the presence of any systematic patterns in 
overseas laboratory ownership by using a sample of 526 Japanese manufacturing 
multinationals. Overseas laboratories are considered to play a major role in 
technological knowledge sourcing from research resources embodied within the host 
countries. Considering that their characteristics are distinctively different from those of 
local-support oriented Research & Development (R&D) units, we take into account not 
only the conventionally examined firm characteristics but also the managerial and 
technological characteristics in estimating the determinants. Our findings are consistent 
with the hypothesis that the ownership decision of overseas laboratories by firms is 
significantly affected by the corporate capabilities to utilise external research resources 
and the science-orientation of industries as well as R&D intensity, global sales, and 
overseas experience of firms. 
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1. Introduction 
 
Research and Development (R&D) is one of the fundamental means for enhancing 
corporate technological capabilities, which is essential for the continual growth of any 
firm. It is widely recognised that R&D activities are deeply interrelated with other 
corporate functions such as administration and production. Therefore, they tend to be 
the last function to be internationalised after the cross-border dispersion of sales and 
production activities. Conventionally, the primary function of overseas R&D activities 
is considered to be the support of local sales and manufacturing activities. Overseas 
R&D facilities adapt the technologies developed in the home country to local input 
conditions, demand conditions, and regulations. However, the speed of technological 
progress taking place at globally dispersed centres of excellence is accelerating and 
there is increasing emphasis on cross-fertilisation across various technological fields. 
This has necessitated firms, particularly in high-tech sectors, to strengthen their 
technological competitiveness not only through their internal R&D efforts, but also 
through an effective utilisation of external research resources regardless of their location. 
Consequently, technological knowledge sourcing (or simply, sourcing) from excellent 
local scientific and technical resources has also been realised as an important 
motivational factor for overseas R&D activities (Kuemmerle, 1997; Granstrand, 1999; 
Iwasa and Odagiri, 2002). 
 
Firms, in general, find it difficult to employ research resources from geographically 
distant countries. Such difficulties are likely to arise from the lack of information on the 
availability of local research resources, and also from the tacit nature of complicated 
and advanced technological knowledge. We consider that overseas laboratories can 
function as an effective means to overcome such distance barriers and allow parent 
firms to utilise excellent, cutting-edge research resources abroad. Overseas laboratories 
primarily engage in research activities and the production of technological knowledge 
with an aim to contribute to the company-wide technological capabilities. They tend to 
possess adequate capabilities to appreciate locally available scientific and technological 
knowledge that are of interest to them and take advantage of first-hand contact with 
local resources. Therefore, overseas R&D laboratories can, potentially, function as 
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representative organisations to undertake sourcing activities. By internalising overseas 
laboratories, firms gain more opportunities to benefit from local technological 
knowledge and bring the knowledge out to the company-wide innovation. 
This paper purports to study if there are any systematic patterns in overseas laboratory 
ownership, particularly focusing on the R&D activities of Japanese multinationals. By 
doing so, we hope to get an insight into the scope of knowledge sourcing from globally 
dispersed research resources. Most of the empirical studies on the determinants of 
overseas R&D are mainly concerned with the local-support-oriented activities and focus 
on the firm’s characteristics such as scale of production/sales, technological complexity 
of products, and overseas experience (Odagiri and Yasuda, 1996; Belderbos, 2003). 
However, our specific area of interest is the ownership of overseas laboratories, whose 
characteristics are distinctively different from those of support-oriented R&D facilities. 
Some surveys (Asakawa, 1996, 2001; Granstrand, 1999) have revealed that knowledge 
management difficulties have a significant influence on overseas laboratory ownership 
as prohibiting factors. We, therefore, consider that conventionally examined factors are 
not sufficient for analysing the determinants of overseas R&D laboratories and take into 
account the characteristics concerning knowledge management and technology, which 
are closely related to the research aspect of firms.  
 
We used a sample of 526 Japanese manufacturing multinationals to test our hypothesis 
that overseas laboratory ownership is affected not only by the conventionally examined 
firm characteristics but also by managerial and technological characteristics. We will 
consider parent R&D intensity, company-wide sales, and overseas experience as 
conventional characteristics. Managerial characteristics are represented by the capability 
to cope with external research resources: We will proxy this with the familiarity to 
commissioned research and technology acquisition. Their effects are expected to vary 
depending on definability of work and predictability of outcome (Odagiri, 2003). 
Furthermore, we will control for the technological characteristics, represented by 
science-orientation and support-orientation of industries, using the data on important 
information sources in commencing an R&D project. 
 
Our estimation results are consistent with the hypothesis: The capability to cope with 
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external research resources, proxied with the familiarity to commissioned research, 
associates positively with the likelihood of overseas laboratory ownership. Thoughwe 
have to be cautious in interpreting the estimation results given that our analysis is 
confined to cross-sectional dimension, this result implies firms that actively employ 
external resources with low definability and predictability are likely to possess 
capabilities to manage external research resources and, consequently, quasi-external 
overseas laboratories in terms of R&D boundaries of firms. Therefore, a higher 
expectation of benefiting from knowledge sourcing encourages firms to invest in 
overseas laboratories. Moreover, the importance of information from universities relates 
positively to the likelihood of acquiring overseas laboratory ownership, while that from 
customers has a negative effect. These results suggest that firms with a strong 
science-orientation have a better incentive to own overseas laboratories in order to seek 
contacts with foreign universities and research institutes; however, this is not true of 
firms with support orientation. 
 
The sections in this paper are organised as follows. Section 2 discusses the determinants 
of overseas laboratory ownership, and our hypotheses based on those arguments are 
presented in Section 3. Section 4 provides a brief discussion on the data and variables 
used for the regression analysis. The estimation results are described in Section 5, 
followed by the conclusion in Section 6.  
 
2. Determinants of overseas laboratory ownership 
 
A conventional function of overseas R&D units is to adapt the technology generated at 
home to the local input conditions, regulations, or tastes of the host countries. By doing 
so, those units purport to support the production and marketing activities of overseas 
subsidiaries. Therefore, their activities are referred to as local-support-oriented. In 
many cases, they collocate with the other functional units, such as production or 
marketing to enable close interactions between them. Information from such internal 
units is relatively valued at local-support-oriented (support-oriented, hereafter) R&D 
units. For example, information from the marketing department on the tastes of local 
customers has much more importance in developing a new washing machine, which is 
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sold at the local market. 
 
On the other hand, the increasing importance of research-oriented overseas R&D 
activities that aim to benefit from local R&D resources is also recognised today 
(Kuemmerle, 1997). The representative institution that undertakes such activities is 
considered to be an overseas laboratory. Thus, we will hereafter focus on overseas 
laboratories, comparing their objectives and activities to those of support-oriented R&D 
units.  
 
The overseas laboratories primarily engage in research activities and aim to generate 
technological knowledge, taking advantage of local research resources. The increasing 
importance of sourcing activities from host countries reflects the emerging consensus 
among firms that it is critical to have access to any scientific discovery and 
technological innovation generated at globally dispersed facilities and, hopefully, use 
them as a seed for further enhancement of their own technological capabilities. Sourcing 
is undertaken through various channels, both formal and informal. For example, the 
subsidiary can hire local scientists or engineers. They can also form collaborative 
research alliances with local universities. Regarding less formal means, analyses on 
patent citation confirm that subsidiaries receive knowledge spillovers from 
neighbouring R&D resources by means of, for example, academic journals or 
attendance at conferences (Frost, 2001; Branstetter, 2000). 
 
Some literatures point out that the activities of overseas laboratories are partly devoted 
to product development designed for the local markets (Pearce, 1999). In such a case, 
close collaboration with local production/marketing units is indispensable for 
innovation and information from internal units should be appreciated, as in the case of 
support-oriented R&D activities. 
 
However, overseas laboratories, particularly in the area of biotechnology and electronics, 
also undertake relatively scientific and basic research. In this case, their objective is to 
enhance the company-wide technological capabilities, and their target is not confined to 
the local markets. Scientific and technological knowledge obtained from external 
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research sources can be valued as a source of innovation rather than those obtained from 
other internal functions. For example, overseas laboratories of pharmaceutical 
companies can conclude consulting agreements with university scientists, hoping for 
scientific findings and new drug development. Between overseas laboratories and the 
headquarters, technological knowledge generated or obtained at the laboratory flows 
from the periphery to centre, which is contrary to that of support-oriented R&D (Bartlett 
and Ghoshal, 1990; Gupta and Govindarajan, 1991). 
 
Ownership of overseas laboratories allows parent firms to appropriate local scientific 
and technical knowledge that is not accessible or obtainable from distant facilities. It 
also allows firms to minimise the inevitable transaction costs in appropriating local 
knowledge. Thus it can be considered as an act to internalise a distant research facility. 
By using overseas laboratories, firms find it easier to collect information on the 
availability of local research resources, to evaluate the information accurately, and 
conclude contracts if necessary. Proximity to the knowledge source is also important 
since knowledge tends to be tacit in nature and first-hand communication is required to 
transfer it. In particular, knowledge transfer from universities, for example by licensing, 
necessitates firms to have a certain amount of direct interaction with the knowledge 
creator before any absorption and development process takes place since such 
knowledge tends to be highly specific and, consequently, tacit in nature. Licensing from 
university is, in effect, shown to be more geographically constrained than mere citations 
of university researches (Mowery and Ziedonis, 2001).  
 
Previous empirical studies on the determinants of overseas R&D activities have 
primarily focused on the activities of support-oriented R&D facilities, reflecting that 
this is the most prominent form of overseas R&D activities (Belderbos, 2003). By 
definition, support-oriented R&D activities are highly affected by overseas production 
and sales activities and also by the technological content of the products developed at 
home R&D facilities. Thus, the analyses on the determinants of support-oriented R&D 
activities, in general, focus on firm characteristics represented by scale of production, 
sales, parent R&D intensity, overseas experience, or entry mode as possible 
determinants. The empirical studies on such R&D activities have confirmed that these 
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characteristics significantly influence the overseas R&D activities (Hakanson and Nobel, 
1993; Odagiri and Yasuda, 1996; Belderbos, 2003). 
 
On the other hand, empirical studies on determinants of overseas laboratories have been 
limited, though prior studies have found sourcing as an important motivational factor 
for overseas R&D, particularly in the US and Europe (Odagiri and Yasuda, 1996; 
Florida and Kenney, 1994). This partly reflects the fact that emergence of overseas 
laboratories is a relatively recent phenomenon and partly the difficulties in obtaining 
micro-level data on overseas subsidiaries. Exceptionally, Odagiri and Yasuda (1996), in 
the industry-level analysis on Japanese firms, have confirmed the importance of firm 
characteristics, such as the scale of subsidiary activities and parent R&D intensity, as 
the determinants of the number of overseas laboratories. 
 
However, as evident, overseas laboratories have distinctively different objectives and 
activities compared to those of support-oriented R&D units. Besides, the outcome of 
overseas R&D activities is different: knowledge sourcing activities by overseas R&D 
units positively affect the home technological capabilities, measured by patented 
inventions, only when firms are committed to relatively research-oriented R&D 
activities abroad (Iwasa and Odagiri, 2002). In fact, some survey results suggest that 
conventional firm characteristics cannot fully explain the ownership of overseas 
laboratories. Even highly R&D intensive, large-scale firms with abundant experience in 
overseas operation recognise the difficulties in managing overseas laboratories 
(Asakawa, 1996, 2001). Based on the survey on 24 R&D intensive, large Japanese 
multinationals, Granstrand (1999) points out that management factors, represented by 
the high costs of coordination and communication, function as the strongest inhibiting 
factors in overseas R&D, while at the same time the firms are highly motivated by the 
establishment of an access to foreign science and technology. Therefore, in addition to 
the conventionally examined firm characteristics, we will also take into account the 
factors that are closely related to research and knowledge management when analysing 
the determinants of overseas laboratories. 
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3. Hypotheses 
 
Our main hypothesis is that corporate characteristics on knowledge management and 
industrial characteristics on technology, which are more closely related to 
research-oriented R&D activities, affect the ownership of overseas laboratories as well 
as the conventionally examined firm characteristics. In this analysis, absorptive capacity, 
firm size, and overseas experience will first be examined following the prior studies. In 
addition to them, we will focus on managerial characteristics represented by capabilities 
to cope with external research resources as well as technological characteristics depicted 
by the science- and support-orientation of industries. 
 
(1) Conventional firm characteristics 
 
R&D intensiveness 
Firstly, firms with high technological capabilities and absorptive capacity are more 
likely to own overseas laboratories with the aim of benefiting from external research 
resources. Higher technological capabilities of firms, which are indicated by high R&D 
intensiveness, suggest that the firms are likely to be in constant need of exploring the 
technological frontier. The geographical proximity, which is enabled by overseas 
laboratory ownership, allows firms to comply with international state-of-the-art 
technological knowledge more easily.  
 
Simultaneously, in order to reap the benefits resulting from overseas laboratory 
ownership, firms are required to possess a certain level of absorptive capacity. Such 
capacity is partly developed through accumulated R&D efforts, and helps firms to 
search, evaluate, and appropriate local technological knowledge efficiently (Cohen and 
Levinthel, 1989). Indeed, firms with higher internal knowledge are considered to be 
capable of exploiting new knowledge generated externally (Arora and Gambardella, 
1990), and they have more incentive to utilise it (Mowery and Rosenberg, 1989). 
Moreover, when the knowledge is generated at a distant location, where the natural, 
social, and economic environment is heterogeneous compared to that of the home 
country, transmitting complicated and advanced technological information among the 
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subsidiaries and the parent company is a demanding task (Von Hippel, 1994). Scientific 
knowledge obtained from research organisations, such as universities, usually 
necessitates further R&D efforts in order to render it applicable for any practical 
purpose (Odagiri, Koga, and Nakamura, 2002). These suggest that a high level of 
absorptive capacity is required for appropriating the benefits from overseas laboratory 
ownership. 
 
It should be noted that the R&D intensiveness of firms also indicates the size of their 
R&D activities. When the size of their R&D activities at home is large, firms are more 
likely to enjoy the economies of scale in R&D at home even after dispersing their R&D 
activities abroad. Subsequently, they can be more responsive to the possible benefit 
from overseas R&D activities and have more incentive to own laboratories abroad. 
 
Firm size 
Secondly, the size of the firm positively affects the likelihood of overseas laboratory 
ownership. Larger firms possess a wider scope to apply the fruit of innovation and 
spread the costs of innovation over their products (Cohen and Klepper, 1996). Therefore, 
if the consolidated size of the firm is large, the firm can expect greater returns from a 
given research outcome of the overseas laboratories and has more incentive for 
ownership. At the same time, the so-called ‘Schumpeter hypotheses’ might be applied to 
the case of overseas R&D activities: Larger firms with, possibly, a higher degree of 
diversification should realise more opportunities to apply the output of their R&D 
compared to smaller firms with a narrow scope of corporate activities. Moreover, large 
firms have an advantage in terms of financial resources: They tend to have relatively 
more cash flow within the firm to cover the investments for overseas laboratories which 
inevitably entails high uncertainty. They are also likely to possess complementary assets, 
represented by extensive sales network, needed to appropriate the innovation. Some 
empirical studies confirmed that large firms tend to employ strategies to seek external 
linkages (Arora and Gambardella, 1990; Odagiri, Koga, and Nakamura, 2002), implying 
that large firms are more eager to own overseas laboratories in order to gain an easy 
access to the offshore scientific resources. 
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 Overseas experience 
The degree of internationalisation, which refers to the extent of overseas experience, 
also affects the likelihood of overseas laboratory ownership. Subsidiaries can gather 
information on the availability of local scientific and technical resources as their 
overseas experience increases. Furthermore, the costs of coordinating and managing 
overseas R&D facilities tend to decrease over time (Granstrand et al., 1993). Certain 
empirical studies have supported the view that the overseas operation encourages 
‘organisational learning’ and the advantage arising from overseas R&D is more likely to 
be realised. An industry-level analysis by Hewitt (1980) confirmed the positive 
influence of experience on the overseas R&D ratio. The analyses on the determinants of 
overseas R&D activities by Japanese manufacturing subsidiaries, which mainly pursue 
support-oriented R&D, have also supported such a hypothesis (Belderbos, 2003). On 
the other hand, in their study on the formation of ‘centres of excellence’ in foreign 
subsidiaries, Frost, Birkinshaw, and Ensign (2002) emphasize that the age of the units 
contributes negatively. The survey statistics of Frost et al. also exhibits that the average 
age of research centres is much lesser than the manufacturing centre, which are 19 and 
34 years, respectively. These results imply that at a subsidiary level, the effects of 
overseas experience could depend on the characteristics of each R&D unit, and an 
expected influence of overseas experience of the firm as a whole is rather ambiguous. 
 
(2) Managerial characteristics 
 
Capability to cope with external research resources 
Using internal R&D facilities abroad as a means to utilise overseas research resources 
rather than the direct purchase of overseas technology by home R&D units is expected 
to allow firms to economise market transaction costs: such costs are associated with, for 
example, searching desirable research partners in foreign countries, concluding 
contracts, and monitoring if partners pursue their task without cheating. However, as 
Williamson (1975) argues, “transactional limits of internal organisation” also needs to 
be considered. Indeed, survey results demonstrate difficulties in cross-border 
management and the consequent under-utilisation of overseas laboratories (Asakawa, 
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1996, 2001), suggesting that the ownership of overseas laboratories inevitably incurs 
large internal organisation costs.  
 
Here, we consider ‘quasi-externality’ of overseas laboratories as a critical source of 
internal organisation costs. The overseas laboratories are fully integrated units of the 
multinationals in terms of shareholding and their R&D activities should be ‘internal’ to 
the firm. However, overseas laboratories can be ‘quasi-external’ in terms of the R&D 
boundaries of firms. This results in an increase in the internal organisation costs. In 
order to tap the local science community and source technological knowledge, the 
laboratory needs to be recognised as one that possesses adequate research capabilities 
and should be able to contribute to the community as one of its members. In other words, 
successful sourcing induces laboratories to localise. When the laboratory increasingly 
sources from local R&D resources, it faces a greater pressure to emulate the 
organisational structures and processes practiced within the host society, deviating from 
those of multinationals, in order to make the interaction with local organisations easier1. 
As the organisational gap between laboratories and headquarters widens, coordination 
between them becomes more difficult (Westney, 1990).  
 
In case of Japanese firms, their overseas R&D activities are generally characterised by 
strong centralisation tendencies. However, their overseas laboratories are given certain 
autonomy so as to respect the local originality (Asakawa, 2001). Moreover, as the 
degree of autonomy of overseas laboratories increases, their external linkages also 
increase (Asakawa, 1996). This implies that the autonomy granted with the aim to 
utilising local research resources, not only brings about successful sourcing, but also 
exerts a strong pull toward the organisational patterns followed within the local societies. 
As a result, the laboratory becomes a ‘quasi-external’ unit within the firm, incurring 
high internal organisation costs.  
                                                  
1 Westney points out three reasons for this ‘isomorphism.’ Firstly, similar 
organisational structures and processes make the inter-organisational interaction 
easier. Secondly, such a change increases ‘legitimacy and acceptability’ both inside and 
outside the constituencies of the subsidiary. Furthermore, given the high uncertainty 
involved within the business activities, managers are likely to seek successful models in 
the formulation of organisational patterns.  
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 Next, we hypothesise that the capability to cope with external research resources 
enables firms to lower internal organisation costs arising from the quasi-externality; 
thus, encourages firms to own overseas laboratories. Such capability is likely to develop 
through the experience to cope with external research resources, i.e. familiarity with 
external research resources. The main providers of external research resources are 
universities, public research institutes, and private corporations. The resources traded 
vary from property rights to other relatively routine services. The resource holders act 
under different legitimacy and cultures and possess different organisational patterns 
from the user firms. The use of these external resources entails management difficulties 
but simultaneously provides the opportunities to enhance the capability to deal with 
them. Therefore, the familiarity with external research resources, through the 
development of management capabilities, encourages firms to own overseas laboratories 
and overcome the problems in managing quasi-external organisations.  
 
External research resources can be differentiated on the basis of ‘definability’ of work 
and ‘predictability’ of outcome (Odagiri , 2003). ‘Definability’ indicates the extent to 
which the firm can predetermine the work to be procured. ‘Predictability’ defines the 
degree to which the firm is able to predict the research outcome. Definability and 
predictability decrease when (1) the time lag between the conclusion of the contract and 
actual implementation of the contracted work increases, and (2) the research task is 
complex. As the definability and predictability of the task becomes low, the difficulty in 
completing the task increases, and its contribution to the capabilities to cope with 
external research resources is supposed to be larger. 
 
If we apply this perspective to the activities of overseas laboratories, the definability and 
predictability of their tasks can be considered as low. Laboratories generally undertake 
forefront and basic-oriented activities and their research tasks are complex. Thus the 
potential of their research output is highly uncertain. Given this, we considered that 
there could be a cross-fertilisation between the experience to utilise external research 
resources with low definability and predictability and the capabilities to manage 
quasi-external overseas laboratories. For example, Eizai, a Japanese pharmaceutical 
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company acclaimed for its active internationalisation strategy in R&D, also actively 
employs external research resources. Eizai has a research laboratory in Boston and also 
benefits from a consulting agreement with a researcher at the Howard Hughes Medical 
Institute in Maryland. Simultaneously, Eizai is active in commissioning research to 
affiliated R&D institutes in Japan (Eizai Annual Report, 2002). Therefore, we 
hypothesise that familiarity with the resources, whose definability and predictability are 
low, contributes positively to the ownership of overseas laboratories. 
 
(3) Technological characteristics of industry 
 
It has been pointed out that the relative importance of support-oriented and 
research-oriented activities is crucial to the firm’s overseas R&D strategy (Von Zedtwitz 
and Gassmann, 2002). At the same time, such orientations are likely to be affected by 
industry characteristics. For example, firms in the pharmaceutical industry tend to 
undertake research-oriented R&D activities not only in the home country but also 
abroad. 
 
The science-orientation of industries is hypothesised to affect overseas laboratories 
ownership positively. In science-oriented industries, science plays an important role in 
innovation and the importance of scientific information is high. Thus, firms in those 
industries are eager to seek links with scientific communities, represented by 
universities and public research laboratories, in order to get first-hand information on 
new findings and to augment the research activities at in-house laboratories. However, 
the emergence of scientific findings occurs simultaneously all over the world. Moreover, 
academic spillovers are more localised than industrial spillovers (Adams, 2001). 
Arundel and Geuna (2001) also reveals that proximity effects are greatest for the 
information from publicly-funded research organisations, which include universities, 
compared to other information sources, such as suppliers, customers, joint ventures, 
competitors. Considering the above factors, namely, globally dispersed scientific 
findings and the importance of geographical proximity in sourcing knowledge from 
academic researches, firms in the industries with strong science-orientation should have 
more incentive to own overseas laboratories and keep access to scientific discoveries 
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abroad. 
 
On the other hand, the industries, in which internal information from the production or 
marketing departments is relatively valued as a source of innovation, are considered to 
be support-oriented. Such industries do not particularly appreciate the knowledge 
obtained from external research resources via overseas laboratories; therefore, they are 
less likely to own it. Firms belonging to these industrial sectors find overseas R&D 
units attached to production or marketing departments more resourceful.  
 
4. Data and Variables 
 
3.1. Data 
 
Since late 1980s, overseas R&D activities undertaken by Japanese firms have been 
increasing. Broadly speaking, the generation of technological knowledge by foreign 
affiliates, measured by patents, was not common among Japanese firms (Patel, 1995) 
and majority of the overseas R&D facilities engaged in adapting technologies developed 
at home to the local conditions. In effect, the number of Japanese overseas laboratories 
was small. Among the 19,385 subsidiaries of Japanese firms listed in the Toyo Keizai 
(1999), only 101 subsidiaries undertook research and development activities 
exclusively.  
 
The sample firms used in this study have been defined using the data from the Survey of 
the Overseas Business Activities (SOBA) of the fiscal year 1997, conducted by the 
Ministry of International Trade and Industry (MITI2). The survey covered all Japanese 
firms3, excluding finance, insurance, and real estate that had a stake in foreign affiliates 
at the end of 1997 fiscal year4. A questionnaire was sent to 3862 parent firms and the 
                                                  
2 It has been renamed as the Ministry of Economy, Trade and Industry or METI. 
3 This includes Japan-based affiliates of foreign firms. Among 530 firms with data 
available for analysis, 63% are wholly Japanese-owned and 33% have more than 80% 
Japanese ownership. In order to avoid the possibility of including overseas laboratories 
which are, in effect, owned by foreign parents, we excluded four firms with more than 
50% foreign ownership from the dataset. Thus our sample consists of 526 firms. 
4 The definition of a foreign affiliate is a “foreign company in which a Japanese 
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response rate was 63. 4%. Among 1407 respondent manufacturing firms, we took a 
sample of 709 firms, based on the availability of information on their R&D activities. 
We matched the 1997 SOBA data with another database on Japanese foreign affiliates, 
the Kaigai Shinshutsu Kigyo Souran 5(1999 edition) in order to identify the ownership 
of R&D laboratories. After the matching procedures, our data consisted of 526 parent 
firms. Among them, 247 firms incurred positive expenditure on overseas R&D activities. 
Table 1 shows a comparison of the sample firms with that of the respondent 
manufacturing firms. It reveals that both the average number of subsidiaries and the 
unconsolidated parent sales are higher among the sample firms, suggesting that our 
sample is biased to larger firms with a higher tendency for globalisation. The two sets of 
data have more or less similar industry structures, though a slight inclination towards 
industries such as pharmaceuticals, chemicals, electronics, and transport machinery is 
recognised.  
 
3.2. Definition of variables 
 
With the sample above, we will estimate the determinants of overseas laboratory 
ownership by Japanese firms using the equation below. In addition to the conventional 
firm characteristics, we take into account managerial and technological characteristics, 
reflecting distinctly different motivation and characteristics of overseas laboratories 
compared to those of support-oriented R&D facilities. Probit estimation method is 
adopted due to the dichotomous nature of the dependent variable (Owns 
laboratory/Does not own laboratory).  
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company owns at least 10% of the stocks.” They consist of subsidiaries and grandchild 
companies, namely, subsidiaries of subsidiaries.  
5 This database serves as a directory of overseas subsidiaries based on a survey 
complied by Toyo Keizai Inc.  
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The dependent variable, LABi, takes 1 if the firm owns more than one overseas 
laboratory and 0 if a firm does not own any. The firm is considered to own overseas 
laboratories if it owns more than one subsidiary whose main activity is exclusively 
research or development in the Kaigai Shinshutsu Kigyou Souran (Toyo Keizai, 1999 
edition). We have not included subsidiaries that exclusively engage in software 
development as research laboratories. It should also be noted that when the chief 
activity of the subsidiary includes both R&D and other functions, such as sales or 
manufacturing, we have not considered the subsidiary as a laboratory. This is because 
the chief task of such subsidiaries is to support the collocating functions, and the 
decision to own it would be based on factors different from those for laboratories. 
 
By following this procedure, we recognised 47 firms as the owners of overseas 
laboratories. Nearly 95% of the lab-owners own only a small number of laboratories: 
68% of them own only one laboratory, while 26% own two. As an exception, one firm 
owned six laboratories. Table 2 shows the laboratory ownership pattern of 526 sample 
firms by the industry. More than 90% of the sample firms do not own any overseas 
laboratories. There are no overseas lab- owners in glass, cement, and ceramics, and steel 
and metal industries though these industries account for approximately 13% of the total 
sample. Among the owners of overseas labs, electronics (23.4%), transport machinery 
(19.1%), pharmaceuticals (17.0%), and chemicals (14.9%) form the majority. 
Particularly, approximately half of the pharmaceutical firms own overseas labs, and this 
confirms the highly research-oriented nature of the industry.  
 
The locations of 68 laboratories are listed in Table 3. Approximately two- thirds of them 
are located in the US. California attracts the largest number of laboratories (13), 
followed by Michigan (7) and New Jersey (5). Eight laboratories are located in the UK. 
Hence, we see a strong geographic concentration in Anglophone countries. In other 
European countries, 5 laboratories were located in Germany and 3 in France and 
Netherlands. China attracts 4 laboratories, highest among Asian countries.  
 
Table 4 depicts the entry modes of the overseas laboratories of sample firms. Of 68 
laboratories, information regarding the mode of entry is available for 46 laboratories. 
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The survey by Frost, et al.(2002) on the formation of centres of excellence shows that 
R&D centres are more likely to be formed within an acquired subsidiary than in a 
greenfield subsidiary. This supports the view that technology acquisition is a 
motivational factor for international mergers and acquisitions. However, unlike the 
survey results, majority of the laboratories owned by our sample firms are greenfield, 
and the utilisation of local technological resources by acquisition or capital participation 
seem to be rare.  
 
Explanatory variables are defined as below. The variables, data source, and summaries 
of the sample data are listed in Table 5. Firstly, the absorptive capacity of the firm as 
well as the scale of R&D activities are depicted by the R&D intensity, RDINTi. RDINTi 
is defined as the ratio of the parent firms’ internal R&D expenses to the parent firms’ 
unconsolidated sales. Higher absorptive capacity and sufficient size for economies of 
scale in home R&D suggests higher incentive to own overseas laboratories; thus, the 
expected coefficient of RDINTi is positive. The R&D intensities of parent firms (called 
home R&D intensity), summarised by lab ownership and industry, are shown in the 
eighth and ninth columns of Table 2. These figures only include in-house R&D 
activities within Japan. In comparison to the ‘no lab’ group, the R&D intensities of the 
‘with lab’ group is higher among the chemicals, pharmaceuticals, general machinery, 
electronics, and transport machinery sectors. On the other hand, R&D intensities of ‘no 
lab’ group are higher in food, oil and coal, and precision machinery sectors. The 
overseas R&D intensities are obtained as a ratio of the R&D expenditure abroad to the 
unconsolidated sales of the parent firms. The overseas R&D intensities are considerably 
lower than at the home R&D intensities, confirming the strong tendency for 
centralisation among Japanese firms. The only exception is observed in the case of ‘with 
lab’ groups in the pharmaceuticals sector. 
 
We also expect the propensity to own an overseas laboratory to be higher when the scale 
of consolidated firm (GSALEi) is larger. We obtained GSALEi, global sales, by summing 
the unconsolidated parent sales and the aggregated subsidiary sales, and used its 
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logarithm for the estimation6. 
  
As stated earlier, the effect of firm-level overseas experience is ambiguous. The units of 
analysis in former studies are primarily subsidiary-level, and the overseas experience of 
each subsidiary is used in the empirical analyses. However, this study adopts firm-level 
experience (EXPi) and the length of operation of the oldest overseas subsidiaries owned 
by the firm, as its units. Figure 1 depicts the year of the establishment of the first 
overseas subsidiaries, which is used as an explanatory variable in our analysis. The 
substantial increase in subsidiary establishment was observed in the second half of the 
1980s. This matches with the so-called ‘economic bubble period’ in Japan. However, 
except for that period, the process of subsidiary establishment is almost evenly spread 
over time. Although the oldest subsidiary in the sample was established in 1936, the 
continuous establishment of overseas subsidiaries commenced from the end of the 
1960s. Figure 2 shows the establishment year of overseas laboratories indicating that a 
pronounced concentration was observed during the second half of 1980s. Despite the 
economic depression after the bubble, the establishment of the overseas laboratories 
continued into the 1990s.  
 
Regarding managerial characteristics of firms, we have introduced three sets of 
variables namely, commissioned research to non-affiliated organisations and affiliated 
firms (NACRi, ACRi), and technology acquisition (TACQi) as proxies for capabilities to 
cope with external research resources.  
 
In terms of commissioned research, the firm outsources the research task to a 
commissioned party, which could either be an affiliated firm or a non-affiliated 
organisation, such as a university, public research organisation, or research firm. The 
commissioned party generally undertakes the contracted research task independent of 
                                                  
6 Although it is preferable is to use consolidated sales to depict global sales, our sample 
includes non-listed firms and such figures are not available. Note that GSALE, which is 
the sum of parent sales including exports and the aggregated subsidiary sales, might 
have a problem of double counting the exports from parent firms. In order to check such 
a bias, we used parent sales instead of GSALE; however, the main results were 
unaffected. 
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the commissioning party. After completion of the research task, the research output and 
possibly its property rights will be transferred to the commissioning party. The 
definability of commissioned research is low since the contract has to be signed before 
the research is undertaken. The predictability is also low, particularly when a 
relatively-basic research-task is outsourced to universities or research organisations, 
because the uncertainty of producing any research output is high.  
 
The variables for commissioned research to non-affiliated organisations, NACRi and to 
affiliated firms, ACRi, are the proportion of expenses on each resource to the corporate 
R&D related expenditure7. The denominator is the sum of expenditures on internal 
R&D, commissioned research (including expenses for foreign organisations), and 
technology acquisitions (including acquisition from foreign organisations). It should be 
noted that the expenditure on foreign universities and public research institutions are 
excluded from the numerator of NACRi and ACRi in order to eliminate the possible 
influence of overseas laboratories ownership on the commissioned researches abroad8. 
Since it is hypothesised that a high reliance on external research resources, which have 
low definability and predictability, associates positively with overseas laboratory 
ownership, the coefficients of both NACRi and ACRi are expected to be positive. 
Furthermore, the magnitude of the coefficient of ACRi is expected to be larger than that 
of NACR.i since the management difficulties of quasi-external organisations should be 
similar to those of affiliated firms rather than non-affiliated organisations, which are 
completely ‘external.’  
 
On the contrary, definability and predictability of technology acquisition are high. The 
                                                  
7 Firm A is considered to be an affiliated firm of firm B, when firm B is either (1) the 
parent firm of firm A, (2) a subsidiary of firm A, or (3) firm A makes more than 20% but 
less than 50% of the investments in total shares /capital stock of firm B. The Basic 
Survey of Japanese Business Structure and Activities of MITI has data on ‘the 
proportion of expenses to affiliated firms.’ Thus we used this information in dividing the 
expenses on commissioned research into affiliated firms and non-affiliated 
organisations. 
8 To be more accurate, this figure may still include the expenses on firms abroad. The 
SOBA defines a foreign affiliate as a foreign company with more than 10% of its share 
owned by a Japanese multinational. Therefore, ACR can include the expenses on 
overseas subsidiaries and NACR can include those of foreign firms with less than 10% 
of the stocks owned by a Japanese parent firm.  
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licensee buys technology, mostly by trading the property rights. The licensee needs to 
possess an adequate absorptive capacity and invest additional R&D efforts before 
converting the acquired technology into a profitable innovation. However, the research 
output is already obtained and the property rights are defined before the trade. Thus, 
unlike commissioned research, the definability and predictably of technology 
acquisition should be high. The variable for technology acquisition, TACQi, is defined as 
the proportion of expenditure on licensed patents owned by domestic organisations9,10 
to R&D related expenditure. Thus, the denominator is the same as that of NACRi and 
ACRi. The payments made to foreign organizations are excluded, once again, in order to 
eliminate the positive effect of overseas laboratory ownership on technology acquisition 
from foreign organisations. Since the definability and predictability of technology 
acquisition are high, TACQi is expected to have no particular influence on overseas 
laboratory ownership. 
 
Despite that, we have to be cautious about the possibility that NACRi, ACRi, and TACQi 
serve as proxies not only for the management capabilities but also for the absorptive 
capacity of firms. After controlling internal R&D expenditure by RDINTi, a high NACRi, 
ACRi, or TACQi indicates large total R&D expenditure including external (procured) 
R&D. Absorptive capacity is developed through the accumulation of knowledge in 
certain fields and corporate R&D contributes to the creation of such a knowledge base 
(Cohen and Levinthal, 1989). Although the main source of absorptive capacity is 
internal R&D activities, successful absorption of research output obtained by 
commissioned research or technology acquisition can also contribute to the 
development of absorptive capacity. Furthermore, the positive effects of NACRi, ACRi, 
and TACQi on the likelihood of overseas ownership might also result from increased 
absorptive capacity due to an expansion of total R&D activities. 
                                                  
9 We cannot deny the possibility that this figure includes the payments made to 
Japanese affiliates of foreign firms. 
 
10 This figure indicates the payments made to licensors in FY1997, and there can be 
time lag between the actual introduction of licensed technology and the payments. 
Moreover, the amount of payments can fluctuate with sales if running royalty is adopted. 
Hence, we cannot deny the possibility that this figure may not correspond to the 
licensing activities of the firm in FY1997. 
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 Table 6 summarises the average expenditure on external research resources by industry, 
comparing the figures for ‘no lab’ with those for ‘with lab’ firms. In terms of the 
proportion of ‘conducting firms,’ 33% of the sample firms, on average, conduct 
commissioned research to non-affiliated organisations, while only 9% of them spend on 
affiliated firms. With regard to technology acquisition, 29% of the sample incurs 
positive expenditure. The difference in the degree of utilising external research 
resources across industries is large. For example, pharmaceutical firms are distinctively 
active in such utilisation: 94% of the sample conducts commissioned research to 
non-affiliated firms, 47% for technology acquisition, while the utilisation of 
commissioned research to affiliated firms remains to 12% of the sample. It can be seen 
that the average expenditure of the ‘with lab’ group on external research resources is 
much larger than that of the ‘no lab’ group. Of all the resources, the gap in the total 
industry figures amounts to more than ten times. At the industry level, these gaps are 
particularly large among electronics firms: ‘with lab’ firms spend more than 50 times for 
any external resource. In terms of the size of average expenditure, the ‘with lab’ 
pharmaceutical firms show the largest amount for both affiliated and non-affiliated 
commissioned research. Interestingly, ‘with lab’ pharmaceutical firms do not spend 
much on domestic technology acquisition, whereas ‘with lab’ firms in electronics 
industry distinctly expend on it. 
 
As for technological characteristics of industries, we have adopted three variables 
regarding the importance of information sources in commencing new R&D projects: 
university (UNIV) for science-orientation, and internal production section (PROD), and 
customers (CUST) for support-orientation. We use the industry-level survey result of 
Goto and Nagata (1996) 11 . This survey on R&D activities and innovation of 
                                                  
11 The result is presented according to the International Standard Industry 
Classification (ISIC) for the purpose of international comparison. In this study, we 
reclassified the results by Japan Standard Industry Classification (JSIC) and matched 
it with the METI industry codes, which are based on 4 digit JSIC codes. It should be 
noted that the METI industry codes correspond to the main businesses of the 
respondent firms. Thus, industry variables used here do not take into account the 
diversified activities of the sample firms. We would like to thank Akiya Nagata for the 
helpful comments on this re-aggregation procedure. 
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manufacturing firms in Japan was based on the Yale survey (Levin et. al., 1987; 
Klevorick et. al., 1995), and implemented in collaboration with the US and European 
researchers in 1994 12 . The questionnaire was sent to 1219 R&D performing, 
manufacturing firms with capitalisation of over 1 billion yen. Responses were received 
from 653 firms (52%). Herein this study, we focus on the source of information in 
commencing new R&D projects for the past three years. We used the proportion of 
firms that obtained information from each resource in commencing R&D projects to the 
total number of firms in the industry. 
 
When the importance of information from universities is high, we consider 
science-orientation of the industry is high. Therefore, we hypothesise that UNIV 
associates positively with laboratory ownership, because firms with high UNIV are 
expected to realise a higher incentive to own an overseas laboratory in order to be 
geographically close to foreign centres of excellence. On the other hand, when an 
industry considerably appreciates the information from internal production, that is, high 
in PROD, we consider the support-orientation of that industry to be high. In this case, 
the expected sign of PROD is negative. We will examine another variable, CUST, which 
measures the industry-level support-orientation with respect to marketing. When the 
information from customers is valued highly in an industry, it is more likely to be 
support-oriented; thus, we expect negative effects on LABi.  
 
In addition to the above variables, industry dummies are included in the estimation in 
order to control for the industry influence that could not be covered by the other 
industry variables, namely, UNIV, PROD, and CUST. ‘The other industry’ is used as the 
base.  
 
5. Estimation results 
 
The empirical findings are consistent with our hypothesis that the likelihood of owning 
overseas laboratories is associated with managerial characteristics of firms and 
technological characteristics of industries as well as the conventional firm 
                                                  
12 For the comparative study of the US and Japanese results, see Cohen et.al. (2002). 
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characteristics. The estimation results of probit regressions are summarised in Table 7 
(subscript i in variable names will be suppressed hereafter). We regress the dependent 
variable, LAB, on R&D intensity of parent firm, global sales, overseas experience, 
familiarity with commissioned research and technology acquisition, and important 
information sources in R&D.  
 
In all the equations, RDINT, the R&D intensity of the parent firm, has significantly 
positive coefficients. This estimated result is consistent with the hypothesis that 
technological capabilities, including absorptive capacity of firms, have a decisive 
influence on overseas laboratory ownership. Although this cross-sectional analysis can 
only confirm a positive relationship between the ownership likelihood and the R&D 
intensiveness without indicating the causality between them, the result agrees with the 
view that absorptive capacity as well as the sufficient economies of scale in R&D at 
home level increase the scope of appropriating the benefit from overseas laboratory 
ownership.  
 
From this finding, we can draw some implications on the concern over hollowing-out of 
the ‘source of technological competitiveness’ to abroad. The research output of 
laboratories is expected to affect the technological competitiveness of firms. In that case, 
the estimation result implies that firms are less likely to own an overseas laboratory 
unless the parent firm has adequate domestic technological capabilities. In other words, 
internationalisation of research activities is constrained by the technological capabilities 
in the home country. It proceeds in a complementary manner, enforcing home and 
overseas research capabilities simultaneously, rather than substituting home laboratories. 
Moreover, it is found that firms cannot source external knowledge of a certain field 
unless they have made R&D investment in that field (Iwasa and Odagiri, 2003). When 
we consider the complementarity of home and overseas research activities together with 
this finding, sourcing from the host country does not occur in a unilateral manner: firms 
cannot simply go abroad and steal the technology they do not have.  
 
The coefficient of global sales, ln(GSALE), also shows a significant and positive 
association with LAB in all the equations. This result implies that when firms penetrate 
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more into foreign markets and their prospect of appropriating the returns from 
innovated products worldwide improves, they tend to have their own overseas 
laboratories aboard. Therefore, as the internationalisation of corporate activities 
advances, establishment of overseas laboratories might increase, and possibly their 
utilisation of those as a means to source technological knowledge abroad might become 
increasingly prevalent. 
 
Overseas experience of the firm, the logarithm of EXP, exhibits a significantly negative 
coefficient in all the equations. In other words, the firms that started overseas operation 
more recently tend to own overseas laboratories compared to the firms with longer 
experience abroad. Although we have to be cautious about the interpretation of this 
result since the overseas experience is measured at the firm level and not the subsidiary 
level, this result agrees with the unit-level analysis on centres of excellence (Frost, et al., 
2002). However, it contradicts the analyses on the determinants of demand-oriented 
overseas R&D activities (Belderbos, 2003). One of the possible explanations for this 
negative association of overseas experience is that firms, which have recently 
established international competitiveness and are eager to strengthen it, possibly 
undertake technology-seeking R&D abroad. Firms that have already established their 
technological competitiveness within the home country and have started 
internationalisation from an early period do not find knowledge-sourcing from centre of 
excellence abroad beneficial enough considering the possible costs. 
 
As for managerial characteristics, it is confirmed that NACR and ACR, the ratio of 
commissioned research to the non-affiliated organisations and affiliated firms 
respectively, both have positive association with the likelihood of overseas laboratory 
ownership. These are consistent with our hypotheses: active utilisation of commissioned 
research, with low definability and predictability, contributes to the development of 
capabilities to cope with external research resources. Then, such capabilities enable 
firms to cope with the task of managing overseas laboratories, of which organisational 
pattern is quasi-external for the firm, and the higher prospect of appropriating the 
benefits from overseas laboratories raises the likelihood of ownership.  
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In terms of magnitude, the coefficient of ACR is larger than that of NACR. This result is 
also consistent with our hypothesis that the difficulties in managing ‘quasi-external’ 
overseas laboratories should be more similar to those in managing affiliated firms, 
rather than completely external non-affiliated organisations. The active utilisation of 
commissioned research to affiliated firms might encourage the firm to establish concrete 
methods and channels to transfer the technological knowledge within the firm. However, 
it should be noted that there is a possibility that ACR includes commissioned research to 
overseas subsidiaries. Thus, a larger magnitude of ACR, compared to NACR, might 
suggest that the firms with high reliance on commissioned research to overseas 
subsidiaries tend to own overseas laboratories, that is, the existence of reverse causality.  
 
The coefficients of technology acquisition from domestic organisations, TACQ, are 
shown to be robustly negative, but they are statistically insignificant. This result agrees 
with our hypothesis that the familiarity with technology acquisition with high 
definability and predictability does not contribute to the development of capabilities in 
external knowledge management; thus it does not have a particular influence on 
overseas laboratory ownership.  
 
As noted earlier, there is a possibility that the positive influence of ACR and NACR is a 
result of increased absorptive capacity: an increase in ACR or NACR, after controlling 
internal R&D by RDINT, is equivalent to that of total corporate R&D including external 
R&D. Then, ACR and NACR can also be considered as proxies for absorptive capacity, 
if we assume that internal and external R&D have similar effects on the development of 
absorptive capacity. However, the estimation results confirm the additional contribution 
of commissioned research on overseas laboratory ownership: The predicted probability 
of overseas laboratory ownership measured at the mean of the dataset is 1.7%. An 
increase of 69 million yen in internal R&D activities, which is 1% of the average 
internal R&D expenditure, raises the probability by 0.02%, while a similar amount of 
increase in commissioned research to non-affiliated and affiliated firms contributes an 
increase of 0.05% and 0.18%, respectively. An additional contribution, at least, can be 
due to the increased managerial capabilities developed through the active employment 
of commissioned research, as we have hypothesised. 
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 Recently, the utilisation of external research resources by Japanese firms has become 
unprecedentedly active, particularly in high-tech industries. In other words, distinctive 
shifts in the R&D boundaries of firms are observed (Odagiri, 2003). The accelerating 
speed of technological change, an increase in relative importance of scientific 
knowledge in innovation of firms, and increased necessity for employing 
complementary technologies have necessitated the firms to seek external research 
resources while focusing their technological strength in specific fields. If such a 
tendency continues, scope for the active employment of overseas research resources by 
the medium of overseas laboratories could possibly widen.  
 
With respect to technological characteristics of industries, the coefficient of UNIV in all 
equations is robustly positive and is statistically significant. As the importance of 
information from universities increases, the likelihood of owning overseas laboratories 
also increases. This result supports the view that the firms in industries with a greater 
science-orientation tend to appreciate the benefits of geographical proximity to foreign 
centres of excellence. On the contrary, the coefficients of PROD and CUST, which 
represents the importance of internal information on production and marketing, are 
found to be negative as we hypothesised. Though statistically insignificant in (1), (2), 
and (3), these results may suggest that firms in industries with greater 
support-orientation do not find ownership of overseas laboratories beneficial.  
 
Finally, eight industry dummy variables are included in equations (2) and (4) in order to 
see if the industry effects are sufficiently covered by the industry-level variables, UNIV, 
PROD, and CUST. Since the dummy variable for miscellaneous is suppressed, the 
coefficients for industry dummies indicate whether the intercepts for these industries are 
different from those of the miscellaneous. Most of the industry dummies do not exhibit 
significant results and the main results are unaffected by the inclusion of dummy 
variables, excluding CUST in equation (4). These results suggest that inter-industry 
differences in overseas laboratory ownership can be adequately depicted by the 
science-orientation and the support-orientation of industries. 
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6. Conclusion 
 
Pioneering technology can never be developed without an accurate grasp of the 
state-of-the-art scientific and technological knowledge. Rapid progress of such 
knowledge is observed not only at home but also abroad. Thus, among the firms that are 
committed to generate break-through knowledge and technologies, effective knowledge 
sourcing across boundaries is increasingly important. Overseas laboratories of 
multinational corporations are indeed one of the crucial means to accomplish this task, 
benefiting from the geographical proximity to local scientific and technological 
resources. 
 
This paper aimed to study the determinants of overseas laboratory ownership using the 
unpublished MITI data on 526 Japanese manufacturing firms. As we have examined, 
the objective and characteristics of overseas laboratories are distinctly different from 
those of support-oriented overseas R&D units. Therefore, in addition to the 
conventionally examined firm characteristics, we took into account managerial and 
technological characteristics, which are closely connected to research aspects of firms, 
in analysing the determinants of overseas laboratory ownership. The empirical results 
were shown to be consistent with our hypotheses. With regard to managerial 
characteristics, the capabilities to cope with external research resources, measured by 
the familiarity with commissioned research, were found to have a positive association 
with the ownership. Moreover, it was found that firms were more likely to own overseas 
laboratories when science orientation of the industry is strong. The other firm 
characteristics, proxied with the R&D intensity of parent firms, global sales, and 
overseas experience, were found to have a significant influence.  
 
Overseas laboratories can potentially function as representative facilities to undertake 
knowledge sourcing on a global basis and contribute to the enhancement of corporate 
technological capabilities. However, the ownership of overseas laboratory is not yet 
prevalent even among firms that possess high technological capabilities and have 
internationalised their corporate activities. Nonetheless, we can infer from our results 
that there would be a greater scope for sourcing excellent research resources from 
 26
distant foreign countries as firms develop their capabilities in employing external 
research resources effectively. Furthermore, active utilisation of overseas laboratories 
might be further encouraged as the technological fields of firms shift toward 
technological frontier, and firms increasingly necessitate the use of scientific knowledge 
in their R&D activities. 
 
By this cross-sectional analysis, we have obtained a clue that the capability-aspect of 
knowledge management might influence the ownership of overseas laboratories. 
However, development of corporate capabilities has an evolutionary nature; therefore, it 
cannot be understood in a static manner. Furthermore, the possibility of simultaneity 
problem cannot be excluded in this cross-sectional dataset. Inevitable difficulties in 
measuring abstract concepts have also been realised, and the proxy attempted here 
should be further improved. Further research needs to be undertaken by improved 
analytical methodologies for accurately understanding the relation between the 
technological knowledge sourcing and the capabilities of firms. 
 
 27
References 
 
Adams, J.D., 2001. Comparative Localization of Academic and Industrial Spillovers. 
NBER Working Paper 8292.  
 
Arora, A., Gambardella, A., 1990. Complementarity and External Linkages: The 
Strategies of the Large Firms in Biotechnology. Journal of Industrial Economics 38, 
361-379. 
 
Arundel, A., Geuna, A., 2001. Does Proximity Matter for Knowledge Transfer from 
Public Institutes and Universities to Firms?. SPRU Electronic Working Paper Series 73.  
 
Asakawa, K., 1996. External-Internal Linkages and Overseas Autonomy-Control 
Tension: The Management Dilemma of the Japanese R&D in Europe. IEEE Transaction 
on Engineering Management 43, 24-32. 
 
Asakawa, K., 2001. Evolving Headquarter-subsidiary Dynamics in International R&D: 
the case of Japanese multinationals. R&D Management 31, 1-14. 
 
Asakawa, K., 2001. Organizational Tension in International R&D Management: the 
Case of Japanese Firms. Research Policy 30, 735-757. 
 
Bartlett, C.A., Sumantra G., 1990 Managing Innovation in the Transnational 
Corporation. In: Bartlett, C., Doz, Y., Hedlund, G. (eds.), Managing the Global Firm, 
Routledge. 
 
Belderbos, R., 2003. Entry Mode, Organizational Learning, and R&D in Foreign 
Affiliates: Evidence from Japanese Firms. Strategic Management Journal 24, 235-259. 
 
Branstetter, L., 2000. Is Foreign Direct Investment a Channel of Knowledge Spillovers? 
Evidence from Japan's FDI in the United States. NBER Working Paper 8015. 
 
Cohen, W.M., Klepper, S., 1996. A Reprise of Size and R&D. Economic Journal 106, 
925-951. 
 
Cohen, W.M., Levinthal, Daniel A., 1989. Innovation and Learning: The Two Faces of 
R&D. Economic Journal 99, 569-596. 
 
Cohen, W., Goto, A., Nagata, A., Nelson, R., Walsh, J., 2002. R&D Spillovers, Patents 
and the Incentives to Innovate in Japan and the United States. Research Policy 31, 
1349-1367. 
 
Eizai, 2002. Eizai Annual Report. 
 
Florida, R., Kenney, M., 1994. The Globalization of Innovation: The Economic 
Geography of Japanese R&D in the U.S.. Economic Geography 70, 344-369. 
 
 28
Frost, T.S., 2001. The Geographic Sources of Foreign Subsidiaries' Innovations. 
Strategic Management Journal 22, 101-123. 
 
Frost, T.S., Birkinshaw, J.M., Ensign, P.C., 2002. Centers of Excellence in 
Multinational Corporations. Strategic Management Journal 23, 997-1018. 
 
Goto, A., Nagata, A., 1996. "Sabei Deta ni Yoru Inobeshon Purosesu no Kenkyu" [ A 
Study of Innovation Process by Survey Data]. unpublished report, National Institute of 
Science and Technology Policy.  
 
Granstrand, O., 1999. Internationalization of Corporate R&D: a Study of Japanese and 
Swedish Corporations. Research Policy 28, 275-302. 
 
Granstrand, O., Hakanson, L., Sjolander, S., 1993. Internationalization of R&D - a 
Survey of Some Recent Research. Research Policy 22, 413-430. 
 
Gupta, A.K., Govindarajan, V., 2000. Knowledge Flows within Multinational 
Corporations. Strategic Management Journal 21, 473-496. 
 
Hakanson, L., Nobel, R., 1993. Determinants of Foreign R&D in Swedish 
Multinationals. Research Policy 22, 397-411. 
 
Hewitt, G., 1980. Research and Development Performed Abroad by U.S. Manufacturing 
Multinationals. Kyklos 33, 308-26. 
 
Iwasa, T., Odagiri, H., 2002. The Role of Overseas R&D Activities in Technological 
Knowledge Sourcing: An Empirical Study of Japanese R&D Investment in the US. 
NISTEP Discussion Paper. 
 
Iwasa, T., Odagiri, H., 2003. Overseas R&D, Knowledge Sourcing, and Patenting: An 
Empirical Study of Japanese R&D Investments in the US. mimeo. 
 
Klevorick, A.K., Levin, R.C., Nelson, R.C., Winter, S.G., 1995. On the Sources and 
Significance of Interindustry Differences in Technological Opportunities. Research 
Policy 24, 185-205. 
 
Kuemmerle, W., 1997. Building Effective R&D Capabilities Abroad. Harvard Business 
Review March-April, 61-70. 
 
Kuemmerle, W., 1999. Foreign Direct Investment in Industrial Research in the 
Pharmaceutical and Electronics Industries - Results from a Survey of Multinational 
Firms. Research Policy 28, 179-93. 
 
Levin, R.C., Klevorick, A.K., Nelson, R.R., Winter, S.G., 1987. Appropriating the 
Returns from Industrial Research and Development. Brookings Papers on Economic 
Activity 3, 783-831. 
 
 29
 30
Mowery, D. C., Ziedonis, A.A., 2001. The Geographic Reach of Market and 
Non-market Channels of Technology Transfer: Comparing Citations and Licenses of 
University Patents. NBER Working Paper 8568. 
 
Mowery, D.C., and Rosenberg, N.,1989. Technology and the Pursuit of Economic 
Growth, Cambridge University Press. 
 
Odagiri, H., 2003. Transaction Costs and Capabilities as Determinants of the R&D 
Boundaries of the Firm: A Case Study of the Ten Largest Pharmaceutical Firms in 
Japan. Managerial and Decision Economics 24, 187-211. 
 
Odagiri, H., Yasuda, H., 1996. The Determinants of Overseas R&D by Japanese Firms: 
an Empirical Study at the Industry and Company Level. Research Policy 25, 1059-1079. 
 
Odagiri, H., Koga, T., Nakamura, K., 2002. R&D Boundaries of the Firm and the 
Intellectual Property System. NISTEP Discussion Paper No.24.  
 
Patel, P., 1995. Localised Production of Global Technology for Global Markets. 
Cambridge Journal of Economics 19, 141-153. 
 
Pearce, R.D., 1999. Decentralised R&D and Strategic Competitiveness: Globalised 
Approaches to Generation and Use of Technology in Multinational Enterprises (MNEs). 
28, 157-178. 
 
Toyo Keizai, 1999. Kaigai Shinshutsu Kigyo Souran. 
 
Von H.E., 1994. "Sticky Information" and the Locus of Problem Solving: Implications 
for Innovation. Management Science Vol.40, 429-439. 
 
Von Zedtwitz, M., Gassman, O., 2002. Market Versus Technology Drive in R&D 
Internationalization: Four Different Patterns of Managing Research and Development. 
Research Policy 31, 569-588. 
 
Westney, D.E., 1990. Internal and External Linkages in the MNC: The Case of R&D 
Subsidiaries in Japan. In: Bartlett, C., Doz, Y., Hedlund, G. (eds.), Managing the Global 
Firm, Routledge. 
 
Williamson, O.E., 1975. Markets and Hierarchies, The Free Press. 
 
 
Sources: Calculated by the author from the Survey of Overseas Business Activities .
Figure 1. Establishment of the First Overseas Subsidiary
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Sources: Calculated by the author from the Survey of Overseas Business Activities .
Figure 2. Establishment Year of Overseas Laboratories
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Table 1. Sample Firms and All Manufacturing Firms with Subsidiaries Abroad: A Comparison
Number of Subsidiaries (A) (B)
Mean 8.048 5.713 1.41
Std.Dev. 13.884 11.252
Min 1 1
Max 207 207
Parent Sales (unconsolidated)
Mean 178,657.4 135,053.4 1.32
Std.Dev. 421,694.0 447,470.2
Min 1,264 0
Max 4,874,526 7,769,486
Number of Parent Firms by Industry
(A) (B)
Food 24 4.6% 78 5.5% 0.82
Chemicals 68 12.9% 140 10.0% 1.30
Pharmaceuticals 17 3.2% 33 2.3% 1.38
Oil and coal 6 1.1% 15 1.1% 1.07
Glass, cement and ceramics 18 3.4% 48 3.4% 1.00
Steel and metal 48 9.1% 136 9.7% 0.94
General machinery 55 10.5% 159 11.3% 0.93
Electronics 113 21.5% 250 17.8% 1.21
Transport machinery 81 15.4% 178 12.7% 1.22
Precision machinery 13 2.5% 46 3.3% 0.76
Other manufacturing 83 15.8% 324 23.0% 0.69
Total 526 100% 1407
Source: Calculated by the author from the Survey of Overseas Business Activities .
Industrial
Composition （A)/(B)
Industrial
CompositionOur Sample
All Manufacturing
with subsidiaries
abroad
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Table 3. Location of overseas laboratories
Country / State
Brazil 1
China 4
France 3
Germany 5
Israel 1
Italy 1
Korea 1
Netherlands 3
Taiwan 1
UK 8
US 40
   of which
       Arizona 1
       Illinois 4
       Ohio 3
       California 13
       New Jersey 5
       New York 2
       Nevada 1
       Pennsylvania 1
       Massachusetts 2
       Michigan 7
       Washington 1
Total 68 40
Number of laboratorie
Source: Calculated by the author from the
Survey of Overseas Business Activities  and
Toyo Keizai
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Table 7. Estimation results: 
(1) (2) (3) (4)
RDINT 11.5694 11.1929 12.9522 11.9119
(3.43)*** (2.93)*** (4.09)*** (3.20)***
ln(GSALE) 0.6538 0.6563 0.6367 0.6561
(8.05)*** (7.78)*** (7.82)*** (7.81)***
ln(EXP) -0.3106 -0.3137 -0.2917 -0.3270
(-2.46)** (-2.32)** (-2.26)** (-2.43)**
NACR 1.3393 1.3899 1.3381 1.2932
(1.93)* (1.95)* (1.83)* (1.82)*
ACR 4.2320 4.3466 4.3021 4.5627
(4.42)*** (3.93)*** (4.43)*** (4.16)***
TACQ -0.2770 -0.3384 -0.2671 -0.3649
(-0.17) (-0.19) (-0.15) (-0.20)
UNIV 1.4258 2.3006 1.1951 2.1766
(2.23)** (2.04)** (1.72)* (2.01)**
PROD -0.7791 -1.8897
(-1.05) (-1.55)
CUST -0.9098 -2.9545
(-1.40) (-2.73)***
food 0.1210 -0.5547
(0.20) (-0.82)
chemical 0.0310 0.2739
(0.05) (0.59)
pharmaceutical -0.8180 -1.1578
(-0.68) (-1.10)
oil 0.0712 -0.5011
(0.09) (-0.60)
machine 0.0047 0.4493
(0.01) (0.95)
electronics 0.3287 0.6786
(0.75) (1.65)*
transport 0.4785 0.6052
(1.12) (1.42)
precision 0.0337 0.0171
(0.04) (0.02)
Constant -8.3213 -8.2014 -7.9512 -7.1171
(-7.53)*** (-6.31)*** (-6.77)*** (-5.67)***
No. of observations 526 526 526 526
Log Likelihood -94.76 -93.00 -94.31 -90.81
Notes:  In parentheses are z statistics. They are calculated based on
robust standard errors to correct for heteroscedasticity.   The level of
statistical significance is as follows: *** 1%, ** 5%, *10%.
Dependent variable: LAB=1 if the firm own more than 1
overseas research laboratory
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要旨 
 
企業が海外の研究資源から知識を得ようとする際、海外に保有する研究所が大きな役割を
果たすことが知られている。本論文は日本の製造業企業５２６社をサンプルとして、企業
の海外研究所保有になんらかの系統だったパターンが見られるかどうかを検証するもので
ある。ここでは、海外研究所の特性が､現地での製造･販売活動のサポートを主な目的とす
る海外研究拠点と異なる点に注目し､企業の研究開発集約度や規模､海外での操業経験とい
った企業特性に加えて､企業の知識マネージメント能力や､産業ごとの技術の性質の影響を
分析に取り入れた。分析の結果､研究集約度が高く､国際レベルでの企業規模が大きく、外
部の研究資源への対応能力が高く､サイエンス性向が高く現地サポート性向が低い産業に
所属する企業ほど、海外研究所を保有する傾向が見られることが確認された。現時点の日
本企業の海外研究所保有は限定的なものであるが､今後企業の研究開発における境界が変
化し、サイエンス型知識の重要性が増すにつれて、海外研究所の利用、さらにそれを経由
した現地の研究資源の活用可能性が増すことが、この研究結果によって示唆される。 
 41
